| HOME >> BIOLOGY >> TECHNOLOGY |
$
2,233$
,026$
37,085$
32,094 Collaborative
3399031,3913,369Total revenue
12,57211,92938,47635,463Operating expenses: Cost of product revenue
7,8337,27823,17920,483Product Gross Profit
4,4003,74813,90611,611Product Gross Margin
36%34%37%36% Research and development
1,4481,6504,1244,808 Selling, general and administrative
7,8389,02421,01024,594Total operating expenses
17,11917,95248,31349,885Operating loss from continuing operations
(4,547)(6,023)(9,837)(14,422)Other Income and Expense: Interest and other expense, net
(2,072)(2,567)(6,179)(8,980) Gain (loss) on debt extinguishment
(3,384)2,511(2,786)8,629 Gain on amendment of 2008 Notes
--3,977--3,977 Gain (loss) on net change in fair value of derivativeassets and liabilities
(299)1,712(1,017)5,078Total other income (expense), net
(5,755)5,633(9,982)8,704Loss from continuing operations before income taxes
(10,302)(390)(19,819)(5,718)Income tax benefit
7,928--7,928--Net loss from continuing operations
(2,374)(390)(11,891)(5,718)Discontinued Operations: Net income (loss) from discontinued operations,net of income taxes
31,980(10,607)9,841(38,715)Less: Loss attributed to noncontrolling interests in consolidated entities – discontinued operations
10,1088,70525,28325,500Net income (loss) attributed to Verenium
$
39,714$
(2,292)$
23,233$
(18,933)Basic and diluted net income (loss) per share:Continuing Operations
$
(0.19)$
(0.04)$
(0.97)$
(0.77)Discontinued Operations
$
2.59$
(1.18)$
.80$
(5.19)Net income (loss) attributed to Verenium
$
3.21$
(0.25)$
.90$
(2.54)Shares used in computing basic and diluted net income (loss) per share
12,3719,01412,2317,466Verenium Corp
'/>"/>
| SOURCE Verenium Corporation Copyright©2010 PR Newswire. All rights reserved |